We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$124B
AUM Growth
+$20B
Cap. Flow
+$16.7B
Cap. Flow %
13.46%
Top 10 Hldgs %
20.91%
Holding
8,008
New
295
Increased
4,222
Reduced
2,579
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 6.83%
2 Financials 5.79%
3 Healthcare 5.06%
4 Consumer Discretionary 4.03%
5 Industrials 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTY
7276
DELISTED
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND
HTY
$7K ﹤0.01%
1,000
SCU
7277
CALL
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$7K ﹤0.01%
+300
New +$5.34K
CEQP
7278
PUT
DELISTED
Crestwood Equity Partners LP
CEQP
$7K ﹤0.01%
200
-1,700
-89% -$60.8K
ZYNE
7279
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$7K ﹤0.01%
520
+20
+4% +$231
SPPI
7280
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$7K ﹤0.01%
800
-1,800
-69% -$16.1K
NYMX
7281
DELISTED
Nymox Pharmaceutical Corp
NYMX
$7K ﹤0.01%
4,878
-3,400
-41% -$5.95K
TCRR
7282
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$7K ﹤0.01%
458
-1,787
-80% -$28.5K
APTX
7283
DELISTED
Aptinyx Inc. Common Stock
APTX
$7K ﹤0.01%
2,055
-2,162
-51% -$7.69K
AMBC.WS
7284
CALL
DELISTED
Ambac Financial Group
AMBC.WS
$7K ﹤0.01%
906
AGFS
7285
DELISTED
AgroFresh Solutions Inc
AGFS
$7K ﹤0.01%
4,750
-3,056
-39% -$7.98K
ALR
7286
DELISTED
AlerisLife Inc
ALR
$7K ﹤0.01%
1,433
DDF
7287
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
$7K ﹤0.01%
508
SMED
7288
DELISTED
Sharps Compliance Corp
SMED
$7K ﹤0.01%
1,944
TLGT
7289
DELISTED
Teligent, Inc
TLGT
$7K ﹤0.01%
1,170
-502
-30% -$4.09K
ICON
7290
DELISTED
Iconix Brand Group, Inc.
ICON
$7K ﹤0.01%
+8,232
New +$10.2K
MEET
7291
CALL
DELISTED
The Meet Group, Inc. Common Stock
MEET
$7K ﹤0.01%
2,000
-5,300
-73% -$23.5K
CTIC
7292
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$7K ﹤0.01%
7,734
-6,136
-44% -$5.66K
YELL
7293
PUT
DELISTED
Yellow Corporation Common Stock
YELL
$7K ﹤0.01%
1,700
-1,700
-50% -$9.83K
HK
7294
DELISTED
Halcon Resources Corporation
HK
$7K ﹤0.01%
38,855
-488,345
-93% -$356K
AMZA icon
7295
InfraCap MLP ETF
AMZA
$461M
$6K ﹤0.01%
100
AP icon
7296
Ampco-Pittsburgh
AP
$177M
$6K ﹤0.01%
1,600
BGFV
7297
DELISTED
Big 5 Sporting Goods
BGFV
$6K ﹤0.01%
3,032
-1,906
-39% -$4.66K
BIB icon
7298
ProShares Ultra NASDAQ Biotechnology
BIB
$82.8M
$6K ﹤0.01%
+120
New +$5.97K
BIS icon
7299
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.28M
$6K ﹤0.01%
43
BKT icon
7300
BlackRock Income Trust
BKT
$331M
$6K ﹤0.01%
338
-65
-16% -$1.16K

Similar funds

Citigroup's Q2 2019 Portfolio in Review

As of Q2 2019, Citigroup held 8,008 positions worth $124B, up 19% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup deployed $16.7B of net new capital in Q2 2019, opening 295 new positions and adding to 4,222 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.12B trimmed.

  • Citigroup's largest Q2 2019 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
  • Citigroup added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $2.43B increase.
  • Citigroup's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.12B.
  • Citigroup fully exited Integrated Device Technology I in Q2 2019, selling an estimated $126M.
  • Citigroup's ten largest holdings make up 21% of its $124B portfolio in Q2 2019.
  • Citigroup opened 295 new positions and closed 217 in Q2 2019.
  • Citigroup's portfolio value rose 19% quarter-over-quarter to $124B.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.